Advertisement
Research program sets the stage for clinical trials
Multidisciplinary team to examine radiation therapy combined with immunotherapy
Notable research chosen by Cleveland Clinic Cancer Center staff
New results from the BLASST-1 trial show increases in downstaging and relapse-free survival
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Study finds that post-cystectomy mortality and survival is associated with socioeconomic factors
Physician interviews reveal increasing use of systemic therapy for Ia/mUC
Community-based data help predict patients’ response to immune checkpoint inhibitors
Assessing surgical approaches while identifying new ones
New findings could shape the treatment paradigm for a select group of bladder cancer patients
Screening assay effective across all stages, can identify tissue of origin
Advertisement
Advertisement